Danaher (DHR) Upgraded to Buy: Here's Why

Danaher (DHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research • Oct 27, 2026

Danaher Q3 Recap: Decent Results, Still A Hold

Danaher Corporation is rated hold, as the stock trades at a small premium and offers an 8.85% expected return, below my threshold. Q3 earnings showed solid performance: revenue up 8.3% YoY to $6.55B, adjusted EPS of $2.11, and strong segment growth, especially in Diagnostics. Key headwinds include respiratory revenue volatility and pricing pressure from China's volume-based procurement, despite some recent positive trends.

Seeking Alpha • Oct 22, 2026

LH vs. DHR: Which Stock Is the Better Value Option?

Investors interested in Medical Services stocks are likely familiar with Labcorp Holdings (LH) and Danaher (DHR). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • Oct 22, 2026

Danaher Beats Profit Estimates, Raises Outlook as Customer Demand Improves

Danaher Corp. (NYSE:DHR) on Wednesday reported third-quarter adjusted earnings of $2.11 per share, beating the analyst consensus estimate of $1.92.

Benzinga • Oct 21, 2026

Danaher: 3 Key Takeaways for Long-Term Investors

Danaher raised full-year earnings per share guidance to $8.57 to $8.62. Biotechnology orders grew mid-teens during the third quarter.

The Motley Fool • Oct 21, 2026

Why Danaher Stock Bounced Higher Today

It beat analyst estimates for both revenue and profitability. Its full-year earnings guidance also topped the pundit consensus.

The Motley Fool • Oct 21, 2026

Danaher Q3 Earnings Call Highlights

Danaher NYSE: DHR reported third-quarter 2026 results that exceeded its expectations, citing improved market conditions, commercial execution and operational performance across its Biotechnology, Life Sciences and Diagnostics businesses.

MarketBeat • Oct 21, 2026

Danaher Corporation (DHR) Q3 2026 Earnings Call Transcript

Danaher Corporation ( DHR ) Q3 2026 Earnings Call October 21, 2026 8:00 AM EDT Company Participants Rachel Vatnsdal Olson - Vice President of Investor Relations Julie Montgomery - President, CEO & Director Matthew Gugino - Executive VP & CFO Conference Call Participants Doug Schenkel Vijay Kumar - Evercore ISI Institutional Equities, Research Division Tycho Peterson - Jefferies LLC, Research Division Jack Meehan - Operon Research, LLC Scott Davis - Melius Research LLC Casey Woodring - JPMorgan Chase & Co, Research Division Elizabeth Koslosky - Goldman Sachs Group, Inc., Research Division Presentation Operator My name is Chelsea, and I will be your conference facilitator this morning. At this time, I would like to welcome everyone to Danaher Corporation's Third Quarter 2026 Earnings Results Conference Call.

Seeking Alpha • Oct 21, 2026

Danaher Reports Third Quarter 2026 Results

WASHINGTON, Oct. 21, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the third quarter 2026.  All results in this release reflect only continuing operations and period-to-period comparisons are year-over-year unless otherwise noted.

PRNewsWire • Oct 21, 2026

Danaher (DHR) Tops Q3 Earnings and Revenue Estimates

Danaher (DHR) came out with quarterly earnings of $2.11 per share, beating the Zacks Consensus Estimate of $1.92 per share. This compares to earnings of $1.89 per share a year ago.

Zacks Investment Research • Oct 21, 2026